Status:
TERMINATED
Allograft Fibrosis Following Pediatric Cardiac Transplantation
Lead Sponsor:
Children's Healthcare of Atlanta
Conditions:
Children Who Underwent Heart Transplantation Prior to Age 18
Received Care at Children's Healthcare of Atlanta
Eligibility:
All Genders
Up to 18 years
Brief Summary
Transplantation is the preferred method of treating many forms of end-stage organ failure. While short-term results have improved, long-term outcomes remain inadequate. Myocardial fibrosis could poten...
Detailed Description
There has been recent evidence that demonstrates a significant racial disparity in outcomes following pediatric heart transplantation.Differences in fibrosis or its regulation may offer an explanation...
Eligibility Criteria
Inclusion
- Children who underwent heart transplantation prior to age 18
- Followed up at Children's Healthcare of Atlanta
Exclusion
- Children without a transplanted heart
- Follow-up not at children's Healthcare of Atlanta
Key Trial Info
Start Date :
January 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2006
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00328185
Start Date
January 1 2006
End Date
December 1 2006
Last Update
March 16 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Healthcare of Atlanta
Atlanta, Georgia, United States, 30329